Cargando…
In Vitro and In Vivo Antiviral Activity of Gingerenone A on Influenza A Virus Is Mediated by Targeting Janus Kinase 2
Janus kinase (JAK) inhibitors have been developed as novel immunomodulatory drugs and primarily used for treating rheumatoid arthritis and other inflammatory diseases. Recent studies have suggested that this category of anti-inflammatory drugs could be potentially useful for the control of inflammat...
Autores principales: | Wang, Jiongjiong, Prinz, Richard A., Liu, Xiufan, Xu, Xiulong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650803/ https://www.ncbi.nlm.nih.gov/pubmed/33050000 http://dx.doi.org/10.3390/v12101141 |
Ejemplares similares
-
Inhibition of porcine epidemic diarrhea virus (PEDV) replication by A77 1726 through targeting JAK and Src tyrosine kinases
por: Li, Xiaomei, et al.
Publicado: (2020) -
Identification of gingerenone A as a novel senolytic compound
por: Moaddel, Ruin, et al.
Publicado: (2022) -
Gingerenone A Induces Antiproliferation and Senescence of Breast Cancer Cells
por: Yu, Tzu-Jung, et al.
Publicado: (2022) -
In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus
por: Jang, Yejin, et al.
Publicado: (2020) -
Ginger (Zingiber officinale) phytochemicals—gingerenone-A and shogaol inhibit SaHPPK: molecular docking, molecular dynamics simulations and in vitro approaches
por: Rampogu, Shailima, et al.
Publicado: (2018)